157 related articles for article (PubMed ID: 38182548)
1. LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c-Myc.
Liu J; Zhu Y; Wang H; Han C; Wang Y; Tang R
Cancer Sci; 2024 Mar; 115(3):804-819. PubMed ID: 38182548
[TBL] [Abstract][Full Text] [Related]
2. LINC00629, a KLF10-responsive lncRNA, promotes the anticancer effects of apigenin by decreasing Mcl1 stability in oral squamous cell carcinoma.
Shi C; Ma C; Ren C; Li N; Liu X; Zhang Y; Wang Y; Li X; Lv P; Han C; Li X
Aging (Albany NY); 2022 Nov; 14(22):9149-9166. PubMed ID: 36445338
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CTSLP8 mediates ovarian cancer progression and chemotherapy resistance by modulating cellular glycolysis and regulating c-Myc expression through PKM2.
Li X; Zhang Y; Wang X; Lin F; Cheng X; Wang Z; Wang X
Cell Biol Toxicol; 2022 Dec; 38(6):1027-1045. PubMed ID: 34510316
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA LINC00629 restrains the progression of gastric cancer by upregulating AQP4 through competitively binding to miR-196b-5p.
Li J; Wang L; He F; Li B; Han R
J Cell Physiol; 2020 Mar; 235(3):2973-2985. PubMed ID: 31674022
[TBL] [Abstract][Full Text] [Related]
5. LINC00629 protects osteosarcoma cell from ER stress-induced apoptosis and facilitates tumour progression by elevating KLF4 stability.
Wang Y; Zheng S; Han J; Li N; Ji R; Li X; Han C; Zhao W; Zhang L
J Exp Clin Cancer Res; 2022 Dec; 41(1):354. PubMed ID: 36539799
[TBL] [Abstract][Full Text] [Related]
6. HOXB4 promotes the malignant progression of ovarian cancer via DHDDS.
Li N; Gou JH; Xiong J; You JJ; Li ZY
BMC Cancer; 2020 Mar; 20(1):222. PubMed ID: 32178630
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA LINC00504 regulates the Warburg effect in ovarian cancer through inhibition of miR-1244.
Liu Y; He X; Chen Y; Cao D
Mol Cell Biochem; 2020 Jan; 464(1-2):39-50. PubMed ID: 31691157
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA GEHT1 promoted the proliferation of ovarian cancer cells via modulating the protein stability of HIF1α.
Liu D; Li H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988076
[TBL] [Abstract][Full Text] [Related]
9. Placenta-Enriched LincRNAs MIR503HG and LINC00629 Decrease Migration and Invasion Potential of JEG-3 Cell Line.
Muys BR; Lorenzi JC; Zanette DL; Lima e Bueno Rde B; de Araújo LF; Dinarte-Santos AR; Alves CP; Ramão A; de Molfetta GA; Vidal DO; Silva WA
PLoS One; 2016; 11(3):e0151560. PubMed ID: 27023770
[TBL] [Abstract][Full Text] [Related]
10. MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.
Zhao S; Zhang X; Shi Y; Cheng L; Song T; Wu B; Li J; Yang H
J Exp Clin Cancer Res; 2020 Dec; 39(1):286. PubMed ID: 33317572
[TBL] [Abstract][Full Text] [Related]
11. Long non‑coding RNA AFAP1‑AS1 facilitates the growth and invasiveness of oral squamous cell carcinoma by regulating the miR‑145/HOXA1 axis.
Li M; Yu D; Li Z; Zhao C; Su C; Ning J
Oncol Rep; 2021 Mar; 45(3):1094-1104. PubMed ID: 33650645
[TBL] [Abstract][Full Text] [Related]
12. Circle RNA hsa_circRNA_100290 serves as a ceRNA for miR-378a to regulate oral squamous cell carcinoma cells growth via Glucose transporter-1 (GLUT1) and glycolysis.
Chen X; Yu J; Tian H; Shan Z; Liu W; Pan Z; Ren J
J Cell Physiol; 2019 Nov; 234(11):19130-19140. PubMed ID: 31187488
[TBL] [Abstract][Full Text] [Related]
13. LncRNA LINC00857 regulates the progression and glycolysis in ovarian cancer by modulating the Hippo signaling pathway.
Lin X; Feng D; Li P; Lv Y
Cancer Med; 2020 Nov; 9(21):8122-8132. PubMed ID: 32918541
[TBL] [Abstract][Full Text] [Related]
14. C-myc/TSPEAR-AS2 Axis Facilitates Breast Cancer Growth and Metastasis in a GLUT1-Dependent Glycolysis Manner.
Xu J; Li T; Zhang Y; Qiu D; Chen N; Chai X; PengLi ; Li J
Biomed Res Int; 2022; 2022():4239500. PubMed ID: 35692593
[TBL] [Abstract][Full Text] [Related]
15. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer.
Gao T; Zhang X; Zhao J; Zhou F; Wang Y; Zhao Z; Xing J; Chen B; Li J; Liu S
Cancer Lett; 2020 Jan; 469():89-101. PubMed ID: 31639424
[TBL] [Abstract][Full Text] [Related]
16. Long non‑coding RNA OIP5‑AS1 facilitates the progression of ovarian cancer via the miR‑128‑3p/CCNG1 axis.
Liu Y; Fu X; Wang X; Liu Y; Song X
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760168
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract][Full Text] [Related]
19. LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc.
Tang J; Yan T; Bao Y; Shen C; Yu C; Zhu X; Tian X; Guo F; Liang Q; Liu Q; Zhong M; Chen J; Ge Z; Li X; Chen X; Cui Y; Chen Y; Zou W; Chen H; Hong J; Fang JY
Nat Commun; 2019 Aug; 10(1):3499. PubMed ID: 31375671
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of long non‑coding RNA CCEPR is associated with poor prognosis and contributes to the progression of ovarian cancer through regulating the Wnt/β‑catenin signaling pathway.
Chen Z; Zhu Y; Fan X; Liu Y; Feng Q
Mol Med Rep; 2020 Apr; 21(4):1950-1958. PubMed ID: 32319633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
